Publications
38
Citations
232
Est. group size
~1
Recurring co-author estimate
Active years
6
Publishing since 2021
Anna Eames Seffernick's research focuses on the genomics and clinical outcomes of blood cancers, particularly acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) in pediatric patients. Recent work examines how genetic ancestry relates to genomic features and survival in T-cell ALL, and how statistical models can help personalize treatment decisions using patient risk scores. This work combines genetic/genomic data analysis with biostatistical methods to better understand and predict disease outcomes.
Publication output was minimal or absent before 2021 but has grown sharply since, with a notable surge in 2025, suggesting a recent and rapidly increasing research output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Correction: Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Blood Cancer Discovery · 2026
- An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup
Science Translational Medicine · 2025
- Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Blood Cancer Discovery · 2025
- Table S6 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S3 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Supplementary Figures S1-S11 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S2 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S7 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S5 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S8 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S9 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S10 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S4 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Table S1 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Data from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025
- Blood Cancer Discovery×2
- Research Square×2
- Nature×1
- Genes×1
- Clinical Epigenetics×1
- Nyla A. Heerema
Medicine · The Ohio State University
- Chunhua Song
Medicine · The Ohio State University
- Y. Li
Medicine · Purdue University West Lafayette
- Susan I. Colace
Medicine · The Ohio State University
- Megan Fleming
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile